MS: Busting the Myths
September 19, 2023 | Treatments
Mavenclad® Cladribine – Have your Say MSNZ is currently preparing a submission to Pharmac to urge them to again consider funding Mavenclad (Cladribine) for Relapsing Remitting MS. Our submission is due this Friday 22nd September. Real world and clinical trial […]
September 14, 2023 | Treatments
Here’s what you need to know about Ocrevus (ocrelizumab) for Primary Progressive MS. Download PDF copy here. What medicines are available to treat Primary Progressive Multiple Sclerosis (PPMS)? There is only one medicine, Ocrevus® (ocrelizumab), that has been […]
September 4, 2023 | Advocacy, Media, Progressive, Treatments
A seven year battle on behalf of hundreds of people living with the most debilitating form of Multiple Sclerosis has been won – with Pharmac agreeing to fund Aotearoa New Zealand’s first ever treatment for the disease variant from October […]
July 27, 2023 | Treatments
Image: myriam-zilles-unsplash Today, the World Health Organisation (WHO) added three Disease Modifying Treatments (DMTs) for Multiple Sclerosis (MS) onto its Essential Medicines List for the first time. Addressing the global MS movement, Prof Mai Sharawy, Chair of the Board of […]
June 1, 2023 | Treatments, Webinar
Multiple Sclerosis New Zealand (MSNZ) and the New Zealand Multiple Sclerosis Research Trust (NZMSRT) are pleased to share with you our aHSCT for MS in New Zealand webinar that marked World MS Day on 30 May. Autologous haematopoetic stem cell […]